Context: Despite the great mortality and morbidity of stroke, treatment options remain limited. We previously showed that JM-20, a novel synthetic molecule, possessed a strong neuroprotective effect in rats subjected to transient middle cerebral artery occlusion. However, to verify the robustness of the pre-clinical neuroprotective effects of JM-20 to get good prognosis in the translation to the clinic, it is necessary to use other experimental models of brain ischemia. Aims: To evaluate the neuroprotective effects of JM-20 following the onset of permanent focal cerebral ischemia induced in rats by thermocoagulation of blood into pial blood vessels of cerebral cortices. Methods: Ischemic lesion was induced by thermocoagulation of blood into pial blood vessels of primary motor and somatosensory cortices. Behavioral performance was evaluated by the cylinder testing for a period of 2, 3 and 7 days after surgery, and was followed by histopathological study in brain cortex stained with hematoxylin- eosin. Results: Ischemic injury resulted in impaired function of the forelimb evidenced by high asymmetry punctuation, and caused histopathological alterations indicative of tissue damage at cerebral cortex. JM-20 treatment (4 and 8 mg/kg) significantly decreased asymmetry scores and histological alterations with a marked preservation of cortical neurons. Conclusions: The effects of permanent brain ischemia were strongly attenuated by JM-20 administration, which expands and improves the current preclinical data of JM-20 as neuroprotector against cerebral ischemia, and strongly support the examination of its translation to the clinic to treat acute ischemic stroke.
1 March 2021 in Journal of Pharmacy & Pharmacognosy Research
Context: JM-20 is a hybrid synthetic molecule, which is based on a multimodal drug design paradigm for cerebrovascular disease. In addition to its neuroprotective effects, JM-20 also decreased sciatic nerve chronic constriction injury (CCI)-induced mechanical hypersensitivity in rats. JM-20 has a strong mitoprotective ability, and its effects could be in correspondence with the mitotoxicity hypothesis for paclitaxel-induced painful peripheral neuropathy. Aims: To evaluate the efficacy of the JM-20 to reduce neuropathic pain manifestations induced by the administration of paclitaxel in rats. Methods: In this study was implemented a rat model of painful peripheral neuropathy, produced by the chemotherapeutic agent paclitaxel, to determine whether JM-20 (10 mg/kg, p.o) could prevent the development of neuropathic pain during the exposure to paclitaxel. As well as to determine whether JM-20 (20 mg/kg, p.o) could reverse the established neuropathic pain. Mechanical behavioral assessment using von Frey filaments applied to the hind paws was applied before, during, and after treatments for 35 days. Results: Giving JM-20 during the exposure to paclitaxel significantly reduced the severity of mechanical allodynia and mechanical hyperalgesia. Moreover, JM-20 significantly reduced both established neuropathic pain manifestations. There was no evidence of tolerance to the effect during three days of dosing, and a long-term effect was observed after JM-20 discontinuation. Conclusions: JM-20 may be clinically relevant for both the prevention and treatment of paclitaxel-induced painful peripheral neuropathy.
14 February 2003 in Acta Crystallographica Section E Structure Reports Online
Context: Drug solubility is one of the most important physicochemical properties for the development of new pharmaceutical products, which, in our study, is a new synthetic molecule, which has been shown to have a potential neuroprotective effect in rat. Aims: To evaluate the equilibrium solubility of JM-20 within the physiological pH range and aqueous chemical stability. Methods: It was performed at pH 1.2, 4.5 and 6.8 at 37 ± 0.5°C for 27 h by the method of the saturated flasks. HPLC and FTIR were used for the study of aqueous stability and to evaluate the molecular structure of the non-ionized fraction by DSC/TGA. Results: Concentrations calculated at pH 1.2 were higher than at pH 4.5 and pH 6.8. A retention time greater than pH 4.5 and 6.8 after 24 h was detected in the aqueous stability study at pH 1.2, in addition to other peaks in these chromatograms. Analyses by FT-IR and DSC/TGA demonstrated the absence of polymorphism in the dissociated fraction of saturated solutions. Conclusions: The JM-20 presented at 6 hours its maximum steady state of solubility, being inferior to pH 4.5 and 6.8. It is corroborated by the qualitative analysis by HPLC, that the compound is chemically unstable from 24 h to pH 4.5 and 6.8. By FT-IR and DSC/TG it was elucidated that the fractions of the molecule not dissociated, did not undergo structural changes in it, and it is inferred that there is no polymorphism.
1 May 2025 in Journal of Pharmacy & Pharmacognosy Research
Context: Translation of any chemical process from laboratory to pilot or commercial scale is by no means a simple linear process. This process is influenced by several parameters, such as temperature, agitation speed, the concentration of reactants, and their interactions. In addition, temperature and agitation speed are very related to heat and movement transfers, which are two critical unit operations that affect the scale-up process and reaction yield. A multicomponent reaction (MCR) is a process where more than three reagents react through two or more reactions, producing one biggest molecule. Its scale-up is complex considering the complex nature of the reaction pathway. Our project involves a 4-MCR for obtaining a 3,4-pyridone derivative, a very important product for obtaining a neuroprotective compound. Despite its importance in medicinal chemistry, no report about the scale-up of MCRs was found. Aims: To develop a practical way to scale up a multicomponent reaction with four components, from laboratory to pilot scales. Methods: A combination of the brute force method and dimensionless numbers was applied for the scale-up process based on the significant physical forces governing the process. Results: Experimentally, it was previously demonstrated that temperature and fluid agitation and their interaction are the most significant parameters affecting reaction yield. Its related unit operations, heat and movement transport, were selected as the critical physical forces for the scaling-up process. The dimensionless numbers related to those unit operations are the Nusselt and Reynold numbers. In addition to other criteria applied, those dimensionless numbers were used to calculate the agitation speed for the upper scale. Likewise, as the reaction product precipitated through the cooling process, the obstruction of the reactor discharge valve was observed. Thus, a critical agitation speed was determined at the laboratory scale by applying the Zwietering rule through direct observation of solid sedimentation in the reactor. Conclusions: The process showed high reproducibility at all scales, reaching good yields of around 73%. Product purity was higher than 99% for all batches. The method applied allows the successful scalability of the process to increase the scale to commercial.